Blockchain Registration Transaction Record

Nightfood's LIM-E Robot Marks Entry into Pharma Automation

Nightfood Holdings (NGTF) subsidiary TechForce Robotics deploys LIM-E autonomous lab robot with Oncotelic Therapeutics, marking expansion into pharmaceutical automation. Read about the RaaS model and growth markets.

This news matters because it signals a significant expansion of robotics into the pharmaceutical and life sciences sectors, which could drastically improve efficiency, accuracy, and safety in laboratory environments. For investors, the successful deployment of LIM-E validates TechForce Robotics' platform versatility and opens new revenue streams beyond hospitality. For the healthcare industry, automation like LIM-E can accelerate drug discovery and reduce human error, potentially leading to faster development of treatments. The collaboration between Nightfood and Oncotelic highlights the growing trend of cross-industry partnerships to drive innovation in automation, impacting how research labs operate and how pharmaceutical companies approach workflow optimization.